Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis

Neuromuscular Disorders

Volumn 21, Issue 3, 2011, Pages 204-213

  Ching, Kathryn H ^a   Burbelo, Peter D ^a   Kimball, Richard M ^b   Clawson, Lora L ^b   Corse, Andrea M ^b   Iadarola, Michael J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AChR; Autoantibodies; Autoantigens; Luciferase Immunoprecipitation Systems (LIPS); Myasthenia Gravis

Indexed keywords

ACETYLCHOLINE RECEPTOR ALPHA1; CHOLINERGIC RECEPTOR; EPITOPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROMYOGRAPHY; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; NEUROTRANSMISSION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RADIOIMMUNOASSAY; RADIOIMMUNOPRECIPITATION; SENSITIVITY AND SPECIFICITY;

ANIMALS; AUTOANTIBODIES; BUNGAROTOXINS; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; COS CELLS; EPITOPES; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MUTAGENESIS, SITE-DIRECTED; MYASTHENIA GRAVIS; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; RADIOIMMUNOASSAY; RECEPTORS, NICOTINIC; TRANSFECTION;

EID: 79951956413     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.12.003     Document Type: Article

References (31)

1. Vincent A., Lang B., Kleopa K.A. Autoimmune channelopathies and related neurological disorders. Neuron 2006, 52:123-138.
2. Vincent A., Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosur Ps 1985, 48:1246-1252.
3. Lennon V.A., Kryzer T.J., Griesmann G.E., O'Suilleabhain P.E., Windebank A.J., Woppmann A., et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995, 332:1467-1474.
4. Kleopa K.A., Elman L.B., Lang B., Vincent A., Scherer S.S. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 2006, 129:1570-1584.
5. Vincent A. Autoantibodies in neuromuscular transmission disorders. Ann Indian Acad Neurol 2008, 11:140-145.
6. Dalmau J., Bataller L. Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications. Neurologia 2007, 22:526-537.
7. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
8. Leite M.I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B.P., et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008, 131:1940-1952.
9. Lefvert A.K., Bergstrom K., Matell G., Osterman P.O., Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosur Ps 1978, 41:394-403.
10. Heinemann S., Bevan S., Kullberg R., Lindstrom J., Rice J. Modulation of acetylcholine receptor by antibody against the receptor. Proc Natl Acad Sci USA 1977, 74:3090-3094.
11. Drachman D.B., Angus C.W., Adams R.N., Michelson J.D., Hoffman G.J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 1978, 298:1116-1122.
12. Vincent A., Willcox N., Hill M., Curnow J., MacLennan C., Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998, 164:157-168.
13. Engel A.G., Lambert E.H., Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 1977, 52:267-280.
14. Corringer P.J., Le Novere N., Changeux J.P. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 2000, 40:431-458.
15. Tzartos S.J., Lindstrom J.M. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 1980, 77:755-759.
16. Tzartos S., Langeberg L., Hochschwender S., Lindstrom J. Demonstration of a main immunogenic region on acetylcholine receptors from human muscle using monoclonal antibodies to human receptor. FEBS Lett 1983, 158:116-118.
17. Tzartos S.J., Seybold M.E., Lindstrom J.M. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci USA 1982, 79:188-192.
18. Loutrari H., Kokla A., Tzartos S.J. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur J Immunol 1992, 22:2449-2452.
19. Sine S.M. Functional properties of human skeletal muscle acetylcholine receptors expressed by the TE671 cell line. J Biol Chem 1988, 263:18052-18062.
20. Lindstrom J., Criado M., Ratnam M., Whiting P., Ralston S., Rivier J., et al. Using monoclonal antibodies to determine the structures of acetylcholine receptors from electric organs, muscles, and neurons. Ann NY Acad Sci 1987, 505:208-225.
21. Kostelidou K., Trakas N., Zouridakis M., Bitzopoulou K., Sotiriadis A., Gavra I., et al. Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor. FEBS J 2006, 273:3557-3568.
22. Psaridi-Linardaki L., Mamalaki A., Remoundos M., Tzartos S.J. Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding. J Biol Chem 2002, 277:26980-26986.
23. Ricny J., Simkova L., Vincent A. Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence. Clin Chem 2002, 48:549-554.
24. Hewer R., Matthews I., Chen S., McGrath V., Evans M., Roberts E., et al. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies. Clin Chim Acta 2006, 364:159-166.
25. Burbelo P.D., Ching K.H., Bush E.R., Han B.L., Iadarola M.J. Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Rev Vaccines 2010, 9:567-578.
26. Burbelo P.D., Leahy H.P., Groot S., Bishop L.R., Miley W., Iadarola M.J., et al. A four antigen mixture containing V-cyclin for serological screening of human herpesvirus 8 (HHV-8) infection. Clin Vaccine Immunol 2009, 16:621-627.
27. Jacobson L., Beeson D., Tzartos S., Vincent A. Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform. J Neuroimmunol 1999, 98:112-120.
28. Liu J., Escher A. Improved assay sensitivity of an engineered secreted Renilla luciferase. Gene 1999, 237:153-159.
29. Loening A.M., Fenn T.D., Wu A.M., Gambhir S.S. Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel 2006, 19:391-400.
30. Lindstrom J., Luo J., Kuryatov A. Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains. Ann NY Acad Sci 2008, 1132:29-41.
31. Irani S.R., Bera K., Waters P., Zuliani L., Maxwell S., Zandi M.S., et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.